Loading provider…
Loading provider…
Rheumatology Physician in La Palma, CA
NPI: 1205833662Primary Employer
ARTHRITIS AND OSTEOPOROSIS MEDICAL CENTER, INC
HQ Phone
Get M.D. Gerald's Phone Numberphone_androidMobile
Get M.D. Gerald's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardCA State Medical License
CA State Medical License
1989 - 2027
HI State Medical License
1991 - 1996

American Board of Internal Medicine
Internal Medicine

American Board of Internal Medicine
Rheumatology
David Geffen School of Medicine at UCLA
medschool.ucla.edu
Medical School
Until 1988
UCLA David Geffen School of Medicine/UCLA Medical Center
Fellowship • Rheumatology
1991 - 1993
UCLA-VA Greater Los Angeles
Residency • Internal Medicine
1988 - 1991
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 1,197 | 3,095 |
| 2 | 96372Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | 374 | 1,114 |
| 3 | 73120X-ray of hand, 2 views | 315 | 637 |
| 4 | 73620X-ray of foot, 2 views | 301 | 608 |
| 5 | 20611Aspiration and/or injection of major joint or joint capsule with recording and reporting using ultrasound guidance | 298 | 1,086 |
Safety and efficacy of abatacept in eight rheumatoid arthritis patients with chronic hepatitis B.
Authors: Daniel Furst, Paul Kim
Authors: Luong, Michael T, Danahy, Paul, Ho, Gerald Y
Journal: Cureus
Publication Date: 2023-07-21
Lead Sponsor: Radius Health, Inc.
Intervention / Treatment: COMBINATION_PRODUCT: abaloparatide, COMBINATION_PRODUCT: abaloparatide solid microstructured transdermal system
Lead Sponsor: Seagen Inc.
Intervention / Treatment: DRUG: Placebo, DRUG: Brentuximab vedotin
Lead Sponsor: R-Pharm International, LLC
Collaborators: IQVIA Pvt. Ltd, OCT Clinical Trials
Intervention / Treatment: DRUG: Concomitant treatment, DRUG: Olokizumab 64 mg SC q4w, DRUG: Olokizumab 64 mg SC q2w